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A parthenogenetic quasi-program causes teratoma-like tumors
during aging in wild-type C. elegans
Hongyuan Wang1,2, Yuan Zhao2, Marina Ezcurra 2,3, Alexandre Benedetto2,4, Ann F. Gilliat2, Josephine Hellberg2, Ziyu Ren2,
Evgeniy R. Galimov2, Trin Athigapanich2, Johannes Girstmair5, Maximilian J. Telford 5, Colin T. Dolphin6, Zhizhou Zhang1 and
David Gems2
A long-standing belief is that aging (senescence) is the result of stochastic damage accumulation. Alternatively, senescent
pathology may also result from late-life, wild-type gene action (i.e., antagonistic pleiotropy, as argued by Williams) leading to non-
adaptive run-on of developmental programs (or quasi-programs) (as suggested more recently by Blagosklonny). In this study, we
use existing and new data to show how uterine tumors, a prominent form of senescent pathology in the nematode Caenorhabditis
elegans, likely result from quasi-programs. Such tumors develop from unfertilized oocytes which enter the uterus and become
hypertrophic and replete with endoreduplicated chromatin masses. Tumor formation begins with ovulation of unfertilized oocytes
immediately after exhaustion of sperm stocks. We show that the timing of this transition between program and quasi-program (i.e.,
the onset of senescence), and the onset of tumor formation, depends upon the timing of sperm depletion. We identify homology
between uterine tumors and mammalian ovarian teratomas, which both develop from oocytes that fail to mature after meiosis I. In
teratomas, futile activation of developmental programs leads to the formation of differentiated structures within the tumor. We
report that older uterine tumors express markers of later embryogenesis, consistent with teratoma-like activation of developmental
programs. We also present evidence of coupling of distal gonad atrophy to oocyte hypertrophy. This study shows how the Williams
Blagosklonny model can provide a mechanistic explanation of this component of C. elegans aging. It also suggests etiological
similarity between teratoma and some forms of senescent pathology, insofar as both are caused by quasi-programs.
npj Aging and Mechanisms of Disease (2018)4:6; doi:10.1038/s41514-018-0025-3
INTRODUCTION
Although aging (i.e., senescence) is now the main cause of mortal
disease worldwide, the causes of senescence (i.e., the etiologies of
diseases of aging) remain poorly understood. Senescence has
been much studied using simple, experimentally tractable model
organisms such as the nematode Caenorhabditis elegans. Major
advances have been made in terms of identifying genes and
pathways that affect C. elegans lifespan, but less so in terms of
understanding the proximate mechanisms of aging that such
genes inﬂuence.1,2
The presence of genes where loss of function increases lifespan
implies that wild-type gene action is a cause of aging. This is
consistent with Williams’ evolutionary principle of antagonistic
pleiotropy (AP): that natural selection can favor alleles that
enhance ﬁtness in early life even if they promote pathology later
in life. This can occur because natural selection declines with age
after the onset of reproduction.3,4
Critical to understanding aging is identiﬁcation of the mechan-
isms by which AP is enacted, i.e., of the pathophysiology of AP,
and there are several theories about this. The disposable soma
theory suggests that late-life costs reﬂect insufﬁcient resource
investment into somatic maintenance mechanisms that reduce
the molecular damage that causes aging (Fig. 1a).5 C. elegans
aging studies regularly make reference to this theory.6–11
In an alternative model suggested more recently, the pre-
dominant cause of life-limiting senescent pathology is not
molecular damage but, rather, non-adaptive continuation of
developmental processes in later life (Fig. 1b).12–14 To describe
such processes the term “quasi-programs” was proposed, to
emphasize that although these are complex, orchestrated,
developmental processes they are nonetheless non-adaptive.
Here developmental is meant loosely, to include e.g., adult
reproductive development and wound healing. To employ an
analogy: “if you left water running after taking a bath, then a
“program” for ﬁlling the bathtub would become a “quasi-program”
to ﬂood your apartment. Unlike a program, a quasi-program has
no purpose (therefore, this does not contradict evolutionary
theory)”.13 Mammalian examples of quasi-programmed processes
(or quasi-programs) include the promotion of cancer in late life by
the senescence-associated secretory phenotype (SASP),15 and of
atherosclerotic plaque formation by inﬂammation, leading to
cardiovascular disease.16 In each case functions that promote
ﬁtness in early life are activated in later life with pathogenic
consequences.
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Here we use this framework of ideas to investigate aging in C.
elegans. Accordingly, we focus on understanding how wild-type
gene action generates senescent pathology. This involves a shift in
approach from what is more traditional in C. elegans biogerontol-
ogy, in that we use senescent pathology rather than lifespan as a
metric of aging: arguably, discovering the origins of senescent
pathologies is key to understanding aging. Our approach involves
a reasonable assumption: that when C. elegans die of old age, it is
as the result of diseases of aging. Moreover, not all late-life disease
promotes mortality, and the identity of life-limiting pathologies
will vary between individuals, culture conditions and species. By
this view, understanding the determinants of lifespan in C. elegans
is less important in terms of applicability to human aging than
understanding the causes of senescent pathology.
Compared to the genetics of lifespan, the biology of diseases of
aging in C. elegans has been relatively neglected, apart from a few
pioneering studies.6,17–19 Wild-type hermaphrodites exhibit a
range of senescent pathologies whose severity and rapidity of
development suggests the action of quasi-programs,20 and which
involve atrophy (e.g., intestine, body wall muscles and gonad) and
hypertrophy (e.g., uterus, some neurons and body cavity
steatosis). The most striking hypertrophic pathology in aging
hermaphrodites is the uterine tumors (also referred to as tumor-
like masses or oocyte clusters).11,21,22 These arise from the
germline of C. elegans hermaphrodites, which initially generates
sperm that are stored in the spermatheca, but then switches to
oocyte production. Oocytes are fertilized as they pass through the
spermatheca until sperm stocks are depleted. After that, some
unfertilized oocytes pass into the uterus where they undergo
major cellular hypertrophy to form tumors so large that they can
ﬁll the entire body cavity in the C. elegans mid-body (Fig. 1c).
Uterine tumors develop in all wild-type hermaphrodites but,
despite their large size, they appear not to contribute to age-
related mortality under standard culture conditions: preventing
their development does not increase lifespan.21,23
C. elegans uterine tumors appear to result from quasi-programs.
It was long ago observed that endomitosis is the “normal
outcome” of entry of unfertilized oocytes into the uterus after
sperm depletion.24,25 In such oocytes there occur multiple rounds
of DNA replication and nuclear envelope breakdown but no
karyokinesis or cytokinesis. This is because the mitotic centriole,
normally supplied by sperm, is missing.25 Such cell cycle run-on
leads to polyploidy, nuclear hypertrophy and, it has been
postulated, eventually to uterine tumors11,18,19 (Fig. 1d).
The goal of this study is to better understand the pathophy-
siological origins of C. elegans uterine tumors, and to investigate
whether they are caused by embryogenetic quasi-programs. This
hypothesis drew on existing knowledge about uterine tumors
from previous studies,11,18,21,22 in particular that by McGee et al.19,
which examined the full course of tumor development. To this
end, we have further characterized the developmental pathology
of uterine tumors with an emphasis on morphometric analysis,
and conducted tests to probe the role of several pathophysiolo-
gical mechanisms.
RESULTS
Correspondence between nuclear hypertrophy and uterine tumor
size
In the previous study by McGee et al.19 tumors were studied in
ﬁxed animals stained with the DNA stain 4′,6-diamidino-2-
phenylindole (DAPI) or with pararosaniline and methylene blue.
To obtain further detail of the biology of tumor development, we
used quantitative analysis of images obtained using Nomarski and
epiﬂuorescence microscopy. In the latter, ﬂuorescent markers
were used, since it is difﬁcult to study the later stages of tumor
development using light microscopy, due to their optical opacity
and disorganized structure.
For the purposes of morphometric characterization of tumor
development, we used a strain with germline-expression of both
HIS-58::GFP to mark chromatin, and mCherry::PH to mark cell
membranes. DAPI staining conﬁrmed that HIS-58::GFP ﬂuores-
cence closely corresponds to nuclear DNA content and the
presence of DNA masses (Figure S1a,b). Our aim was to
characterize the development of nuclear hypertrophy, and its
relationship to cellular hypertrophy, and the nature of the
transition from orderly spherical nuclei to disordered DNA masses.
Casual observation of images obtained using selective plane
illumination microscopy (SPIM) conﬁrmed the occurrence of
marked nuclear hypertrophy with increasing age (Fig. 2a, b).
A semi-quantitative approach was used to characterize the
dynamics of such hypertrophy, scoring nuclear status from 1
(normal sized, spherical nucleus) to 5 (nuclei merged into large
masses of chromatin). The main period of tumor growth was
between days 2 and 6 (Fig. 2c), as previously described.21 During
the initial phase of nuclear growth (day 2–4), nuclear morphology
remained normal (spherical), but from day 6 it became
progressively irregular in appearance (Fig. 2b, d). With increasing
hypertrophy nuclear masses developed protrusions and then
large, branching extensions (Fig. 2b, d), which by day 8 became so
large, extensive and random in structure that it became difﬁcult to
distinguish individual nuclei, which merged into amorphous
masses of chromatin (Fig. 2a, b; see Video S1, S2 for 3D views of
changes in nuclear morphology). Nuclear morphology and tumor
size were positively correlated (Table S2), likely reﬂecting
correspondence between nuclear size and morphological
complexity. Although tumors reach a maximal size by day 6,
chromatin masses continue to increase in size and morphological
complexity until day 8 (Fig. 2c, d). A positive correlation was also
seen between tumor size (day 6) and the number of oocytes
within each tumor (as inferred from the number of oocyte nuclei)
(Fig. 2e); thus, tumor size is partly determined by number of
oocytes in the uterus, and partly by the extent of oocyte
hypertrophy.
Nuclear hypertrophy was initially more marked at the proximal
end of the tumor, nearest the vulva (Fig. 2f), consistent with the
greater age and more advanced patho-developmental stage of
proximal cells. This proximal-distal gradient in hypertrophy
disappeared in fully developed tumors (Figure S1c) as all nuclei
approached their upper limit of hypertrophy.
Previous quantitative analysis by PCR showed a ~4-fold increase
in genomic DNA copy number that coincided approximately with
the appearance of DAPI-stained masses and uterine tumors.18,19
To test this in more detail we compared the timing of quantiﬁed
age increases in intra-uterine chromatin (using HIS-58::GFP) and
total worm DNA content (using PCR) and observed an overall
correspondence (Figure S1d,e). The initial decline in DNA content
could reﬂect disappearance of embryos, and the late decline in
GFP ﬂuorescence could result from ﬂuorophore breakdown. These
results conﬁrm that the late-life increase in DNA content is
attributable to uterine tumor development, as previously
proposed.18,19
Similarities between C. elegans uterine tumors and mammalian
ovarian teratomas
Can one learn about human disease etiology by studying
senescent pathology in C. elegans? This depends on the existence
of shared pathophysiologies. Background reading led us to
identify a mammalian pathology with an etiology resembling
that of C. elegans uterine tumors: ovarian teratoma. In C. elegans
the ﬁnal stages of oocyte maturation, including completion of
meiosis I and II, occur after fertilization, but in oocytes that remain
unfertilized meiosis ceases after anaphase I.26 Thus, C. elegans
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Fig. 1 Theories of aging and uterine tumor development. a, b Alternative models for how wild-type genes cause senescence (pathogenic
action of alleles exhibiting antagonistic pleiotropy). a Disposable soma model. Wild-type genes promote reproduction at the expense of
somatic maintenance processes that prevent the damage that causes aging. b Williams Blagosklonny model. Continued action of wild-type
genes in later life leads to run-on of developmental programs (quasi-programs) causing development of senescent pathology. c, d Senescent
uterine tumors in C. elegans hermaphrodites. c Stages of development of uterine tumors. Dotted lines delineate uterine contents. Scale bar, 50
μm. d Schematic representation of uterine tumor development, consistent with Williams Blagosklonny model. As argued in this study, the
point of origin of pathophysiology is immediately after fertilization with the last sperm in the spermatheca; this is the point of transition from
program to quasi-program. Red, promoting senescent pathology
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uterine tumors develop from diploid immature oocytes (Fig. 3a).
Similarly, mammalian ovarian teratomas arise from initiation of
embryonic programs in unfertilized oocytes. Here maturing
oocytes complete meiosis I but do not undergo meiosis II, and
are thus diploid but homozygous at most loci.27,28
Teratomas are a form of benign tumor generated by activation
of developmental programs in the wrong context. In humans,
10–20% of abnormal ovarian neoplasms are teratomas. Within
such tumors growth and differentiation can give rise to multiple
tissue types and complex structures, most commonly skin, hair,
muscle, and cartilage29 (Fig. 3a). Other forms of teratoma can form
more complex structures including bone, teeth and even partial
fetuses; the grotesque appearance of some teratomas accounts
for their name (tera, Greek: monster).
In mammalian ovarian teratomas inappropriate expression of
embryogenetic programs leads to pathological embryonic differ-
entiation and morphogenesis;27 thus teratomas may be under-
stood to result from quasi-programs. We wondered whether
anything similar occurs within C. elegans uterine tumors. To this
end, we ﬁrst examined expression of ﬁve genes expressed in
various embryonic and adult tissues but not in oocytes, elt-1
(sperm-producing germ line), elt-2 (intestinal expression), hlh-1
(muscle), pha-4 (pharyngeal and intestinal expression), and unc-
119 (pan-neuronal), using GFP or EGFP reporters, in tumors on
days 2, 4, 6, 8, and 13 of adulthood. A previous study saw no
muscle or neuronal reporter expression in wild-type, polyploid
unfertilized oocytes from 2 to 2.5 day old adults.30 Consistent with
this, we saw no reporter gene expression in the early stages of
Fig. 2 Further characterization of senescent uterine tumors. a Nuclear hypertrophy during tumor development (representative images of
different animals). Scale bar, 25 μm. b Development of nuclear hypertrophy. Scale bar, 15 μm. c Uterine tumor development during aging.
Uterine status scale: class 1, normal uterus containing eggs (day 1 adult). Class 2, slightly abnormal uterine contents, but no tumor visible.
Class 3, small tumor. Class 4, medium sized tumor. Class 5, large tumor, ﬁlling body cavity and squashing the intestine. d Changes in nuclear
morphology during tumor aging. Nuclear morphology scale (predominant morphology in tumor): class 1, normal sized, spherical nuclei. Class
2: moderately enlarged, spherical nuclei. Class 3: very large nuclei becoming non-spherical. Class 4: very large nuclei with frequent branching.
Class 5: nuclei merged into large masses of chromatin. c, d day 0 is L4 stage; each point represents one tumor, and the same individuals were
scored for each parameter; Wilcoxon–Mann Whitney test, ****p < 0.0001. e Linear regression analysis of number of oocyte nuclei and tumor
size. f Nuclear hypertrophy is initially more marked in the proximal half of the tumor. Measured as HIS-58::GFP ﬂuorescence intensity (mean ±
s.e.m.); unpaired t-test, *p < 0.05; **p < 0.01. Sample sizes on each day: n= 9–24
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tumor development. However, in late-stage tumors, after chro-
matin mass formation, expression of all reporters was seen, unc-
119 and pha-4 from day 4 and elt-1, elt-2 and hlh-1 from day 8 or
13 (Fig. 3b, c). Expression was variable, occurring in some tumors
but not others, and varying in intensity in different regions of
expression-positive tumors.
Analysis of reporter expression in tumors was complicated by
the fact that uterine tumors sometimes contain fertilized eggs
embedded within them. In some cases, such embedded embryos
appear to be developing normally, but others are degenerated
(Figure S1f). Such embedded embryos were rarely seen in tumors
of older animals. Examination of ﬂuorescent regions within tumors
using bright ﬁeld microscopy did not reveal the presence of
embedded embryos (data not shown), conﬁrming that tissue
derived from unfertilized oocytes was expressing embryonic
genes.
Fig. 3 C. elegans uterine tumors are teratoma-like. a C. elegans uterine tumors and human ovarian teratomas are etiologically similar in that
both originate from action in unfertilized immature oocytes of quasi-programs initiated after failure of meiosis II. b, c Expression of embryonic
reporters in later stage uterine tumors. b Selected images of early and late stage tumors (epiﬂuorescence microscopy). Note no ﬂuorescence in
early embryos (arrows). Expression was detected in older tumors (arrowheads). Scale bar, 50 μm. c Frequency of tumors expressing ﬂuorescent
markers at different levels (1–3 scale). Scale bar 50 μm. Score of reporter ﬂuorescence within tumor: score 1, no ﬂuorescence; score 2, weak
ﬂuorescence; score 3, strong ﬂuorescence. GFP ﬂuorescence in uterine tumors (arrowheads: ﬂuorescence). Scorer was not blind to the
treatment group. All trials, n ≥ 19. Teratoma image courtesy of E. Uthman http://web2.airmail.net/uthman/specimens/images/teratoma.html
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The earlier appearance of punc-119::GFP expression is notable
since embryonic expression of this reporter occurs earlier than the
others, and was visible in embryos even before egg laying (Fig.
3b). This suggests that the order of expression of embryonic
markers may follow the same sequence as that in embryogenesis,
consistent with recapitulation of embryonic programs within the
tumor. To test this further we combined punc-119::mCherry and
pelt-2::EGFP reporters in the same strains, and conﬁrmed the
earlier expression of punc-119::mCherry (Figure S2a,b). Notably, the
different markers were expressed at different locations within
tumors (Figure S2b). Red ﬂuorescence from punc-119::mCherry was
distinguishable from naturally occurring red autoﬂuorescence (see
below), as the former was far brighter and more widely distributed
(Figure S2c).
In mutationally-induced C. elegans germline teratomas, as in
mammalian teratomas, germ cells transdifferentiate into various
somatic tissues including intestine, muscle and neurons.30 It
seemed to us unlikely that actual tissue differentiation occurs in
wild-type uterine tumors, since these are formed from a small
number of large, hypertrophic cells. To explore this we looked for
the presence of several markers of tissue differentiation: blue
autoﬂuorescent gut granules (intestine), expression of unc-119::
GFP in ﬁlamentous processes (neuron), and expression of myo-3::
GFP in a striated pattern (muscle), but in no case was
differentiation detected (data not shown). MYO-3::GFP ﬂuores-
cence was sometimes seen in embedded embryos (Figure S2d). To
verify that such ﬂuorescence issued from embedded embryos
rather than teratomas, we examined a fertilization defective rrf-3
(b26); edIs6 [unc-119::GFP+rol-6(su1006)] strain. rrf-3(b26) largely
abrogated MYO-3::GFP ﬂuorescence within tumors (Figure S2e).
Overall, these results imply that older uterine tumors to some
extent recapitulate embryonic gene expression programs, but that
this does not lead to full blown teratomas with embryonic
differentiation, perhaps due to the absence of cell proliferation.
Thus, C. elegans uterine tumors resemble mammalian ovarian
teratomas in that (a) both originate from diploid cells resulting
from a failure in meiosis II in oogenesis (Fig. 3a) and (b) both
develop due to inappropriate switching on of embryogenetic
programs (i.e., from parthenogenetic quasi-programs).
Evidence that tumor development is initiated by sperm depletion
To understand a disease one wants, ideally, to identify its initial
cause. For example, the original cause of malaria is the bite of an
Anopheles mosquito that transmits protozoa of the genus
Plasmodium. Long-standing questions in research on aging are:
what is the origin of senescence? When and how exactly does it
begin? Does such a starting point even exist? In the case of C.
elegans uterine tumors this question may be answered: the likely
point of origin of pathology, equivalent to the mosquito’s bite, is
the departure of the last functional sperm from the spermatheca.
This marks is the point of transition from program to quasi-
program. Shortly thereafter, the ﬁrst unfertilized oocyte enters the
uterus and begins to undergo endomitosis, and the pathogenetic
process begins that eventually generates gross, teratoma-like
senescent pathology.
According to this account it should be possible to accelerate or
delay the development of uterine tumors by bringing forward or
delaying sperm depletion, i.e., altering the timing of the mosquito
bite (the transition from program to quasi-program). To test this
we ﬁrst examined fog-2(q71) mutants which, due to germline
feminization, do not produce sperm thereby changing hermaph-
rodites into females.31 Tumors were found to develop earlier in
fog-2 females than in N2 hermaphrodites (Figure S3a; day 1–3 of
adulthood). By contrast, tumor formation was suppressed by
mating in both fog-2 females and N2 hermaphrodites (Figure S3b-
d). Thus, altering the timing of the transition from program to
quasi-program alters the rate of development of the senescent
pathology that the quasi-program generates. Tumors also failed to
grow in fem-3(q20) mutants which produce sperm but not oocytes
(Figure S3e), conﬁrming that tumors develop from oocytes.
Identiﬁcation of genes contributing to tumor development
If uterine tumors result from embryogenetic quasi-programs, then
this predicts that many genetic determinants of key functions in
early embryogenesis (e.g., DNA replication, the cell cycle and
protein synthesis) (Table S1) will promote tumor development. To
explore this we used RNAi to inhibit function of candidate genes,
testing for suppression of tumor growth. To increase sensitivity in
these assays, we measured tumor size (cross-sectional area) rather
than scoring pathology level.
We ﬁrst performed whole worm RNAi. Interventions that retard
oocyte production rate are predicted to delay sperm depletion,
and consequently the onset of tumor development. We therefore
ﬁrst tested RNAi initiated on day 3 of adulthood, to try to limit the
effect of gene knockdown to the period after sperm depletion.
Four genes involved in protein synthesis (rps-1, egl-45, iff-1, and
phi-2) also served as positive controls, since RNAi was known to
inhibit germline development.32 Here RNAi reduced tumor size,
showing efﬁcacy of RNAi within the uterus, but did not affect
nuclear size (Fig. 4a). Of other knockdowns, only that of wee-1.3
reduced tumor size. However, in most cases a signiﬁcant reduction
of nuclear hypertrophy was seen.
The lack of effects on tumor size could reﬂect weak reduction of
gene function. We therefore tested RNAi initiated earlier, on L4
and day 1 of adulthood, and this resulted in major reductions in
both tumor size and nuclear hypertrophy in most cases (Fig. 4b).
This included inhibition of genes involved in DNA replication (e.g.,
mcm-4 and pri-1) and cell cycle promoters (e.g., cye-1 and cdk-1).
RNAi did not reduce body size, even when initiated at L4 (Figure
S4a), nor was tumor size correlated with body size in wild type
(Figure S4b), thus RNAi effects on tumors were not attributable to
altered worm size. Again RNAi of most protein synthesis genes
caused reduction of tumor growth but not of nuclear hypertrophy
(apart from rps-1 RNAi, which reduced both).
To check that reduction in tumor size were not merely the result
of a delay in sperm depletion, we examined the effect of RNAi of
selected genes on reproduction (Fig. 4c). RNAi of cye-1 and cdk-1
from L4 and day 1 did not delay the reproductive schedule,
indicating that the timing of sperm depletion was unaffected.
We then veriﬁed that RNAi effects on tumor growth reﬂect gene
action in the germline by using ppw-1(pk1425) which causes the
germline to be RNAi resistant, and rrf-1(ok589) which attenuates
somatic but not germline RNAi (Figure S4c,d). ppw-1 blocked RNAi
effects on tumor growth for genes encoding DNA replication and
cell cycle function but, notably, tumor growth was still reduced by
RNAi of several genes promoting protein synthesis, egl-45, iff-1,
and rps-1 (Figure S4c). One possibility is that this is due to reduced
intestinal synthesis of yolk which, as described below, feeds tumor
growth. By contrast, rrf-1(ok589) had little effect on RNAi inhibition
of tumor growth (Figure S4d).
These results provide evidence that the function of wild-type
genes specifying functions required for early embryonic develop-
ment, including the cell cycle and protein synthesis, promote
growth and reproduction in early life and senescent uterine tumor
development after reproduction, another example of antagonistic
pleiotropy as run-on.3,14 This is clearest with respect to nuclear
hypertrophy; with respect to overall tumor size, the possibility that
RNAi reduces the number of oocytes entering the uterus has not
been ruled out.
Uterine tumor hypertrophy is coupled to distal gonadal atrophy
wee-1.3 encodes a CDK inhibitory kinase, and we therefore
expected that wee-1.3 RNAi would enhance uterine tumor growth
but, surprisingly, the opposite effect was seen (Fig. 4a, b).
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However, wee-1.3 RNAi also resulted in a novel phenotype:
development in the distal gonad of additional tumors formed, like
uterine tumors, from a small number of large, hypertrophic cells
with enlarged nuclei (Fig. 5a). This suggests that loss of CDK
inhibition in the distal gonad leads to cellular hypertrophy.
One possibility is that development of distal gonad hyper-
trophic tumors somehow causes the observed reduction in uterine
tumor size. Consistent with this, the sum of the mean cross-
sectional area of uterine tumors and distal gonad was constant in
day 4, day 8, and day 12 adults (Fig. 5b). However, in a comparison
of the size of the two tumor types in individual worms, we were
unable to detect a negative correlation (data not shown).
Next we asked whether anything similar might occur in wild-
type hermaphrodites. In wild-type hermaphrodites, one uterine
tumors develops at each distal end of the uterus. Anterior and
posterior tumors are, on average, similar in size (Figure S4e), and
tumors in a given worm are usually similar in size (Figure S4f).
However, marked tumor size asymmetry occurs in a small fraction
of worms (<5%). Interestingly, the majority (~80%) of those
animals also show corresponding asymmetry in the degree of
distal gonad atrophy (Fig. 5c, d). This suggests the presence of a
common etiology promoting both uterine tumor growth and
distal gonad atrophy; one possibility is that resources released by
distal gonad atrophy support tumor growth, another that signals
Fig. 4 Knockdown of genes required for early embryogenesis reduces tumor growth. a, b Effects of whole worm RNAi initiated at different ages
on nuclear hypertrophy and tumor size (mean ± s.e.m.), measured on day 8 of adulthood. Dunnett multiple comparison test, Wilcoxon–Mann
Whitney test, *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. All trials, n ≥ 17. a RNAi initiated from day 3. b RNAi initiated from L4 and day 1. c
Effects of cye-1 and cdk-1 RNAi on fertility schedule (progeny and unfertilized oocytes). All trials, n ≥ 9. Data are mean ± s.e.m
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from the tumor promote atrophy of the attached distal gonad.
Coupling of uterine tumor hypertrophy and distal gonad atrophy
could explain how RNAi of cdk-1 and wee-1.3 both inhibit tumor
growth despite their opposing effects on the cell cycle: by
suppressing distal gonad atrophy, wee-1.3 RNAi also suppresses
uterine tumor growth.
Quasi-programmed yolk uptake also contributes to tumor growth
Prior to ovulation, maturing oocytes import yolk (vitellogenin and
yolk lipid) from the body cavity using the LDL receptor-like protein
RME-2.33,34 Previous analysis of stained, ﬁxed sections of aged
hermaphrodites showed high levels of yolk between tumor cells in
the uterus.19 This raises the possibility that futile yolk import by
oocytes in the uterus contributes to tumor growth, e.g., by
increasing their bulk through its presence, or by providing nutrients
to support new biosynthesis within tumor cells. Consistent with this,
tumors in a C. elegans strain expressing a GFP-tagged vitellogenin,
VIT-2::GFP, show strong green ﬂuorescence (Fig. 6a, Figure S5a,b; see
Video S3 for 3D view). Moreover, staining of neutral lipids in ﬁxed
worms with the ﬂuorescent dye Bodipy showed high levels of lipid
within tumors (Fig. 6b).
To test this further, we used combined RNAi of vit-5 and vit-6
initiated at L4, which largely abrogates yolk accumulation in
adults,35 and found that it reduced tumor size (Fig. 6c). RNAi of the
rme-2 yolk receptor from L4 had a similar effect (Fig. 6d). To test
whether yolk uptake after ovulation contributes to tumor growth
we compared effects of vit-5,-6 RNAi initiated at L4, day 1, 3, or 6 of
adulthood, and saw signiﬁcant reduction in tumor size in all cases
(Figure S6a, Table S3). We also detected an age increase in VIT-2::
GFP ﬂuorescence within tumors (Figure S6b). Increasing vitello-
genin levels using the bIs1 VIT-2::GFP transgene array did not
increase tumor size (data not shown), perhaps because wild-type
yolk levels are not limiting for tumor growth. Taken together these
results support the view that yolky lipid pools that accumulate in
the body cavity6,17 promote further pathology by feeding uterine
tumors.
Fig. 5 Evidence for coupling of uterine tumor growth and distal gonad atrophy. a Distal gonad tumors resulting from wee-1.3 RNAi (CDK
inhibitory kinase). Yellow dotted line delineates uterine tumors, white dotted lines distal gonad hypertrophic tumors, and red dotted lines
gonad. Bottom right: The size and number of HIS-58::GFP-labeled nuclei indicate that these tumors, like uterine tumors, result from cellular
hypertrophy rather than hyperplasia. Arrowhead, hypertrophic nucleus. T uterine tumor, DT distal gonad hypertrophic tumor. Scale bar, 50 μm.
b Quantitation of effects of wee-1.3 RNAi on uterine and distal hypertrophic tumor size; note lack of change in combined size. Sidak multiple
comparison test, *p < 0.05; ****p < 0.0001. Sample sizes: L4440, day 4, n= 12, day 8, n= 13, day 12, n= 20; wee-1.3 RNAi, day 4, n= 26, day 8, n
= 14, day 12, n= 22. Data are mean ± s.e.m. c, d Asymmetry in gonad disintegration in animals with asymmetrical uterine tumor pairs. c Day 19
adult with asymmetric tumors (T), and asymmetric gonadal atrophy (delineated with black dotted line). Scale bar, 100 μm. T tumor. d Ratio of
anterior tumor/posterior tumor size and gonad size within the same worm with asymmetric tumors (10 μM FUDR) on day 9 and day 10. n= 15
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Uterine tumors can develop bacterial infections
We also noted that wild-type C. elegans maintained on E. coli
expressing the red ﬂuorescent protein dsRed sometimes develop
strong red ﬂuorescence within tumors (Fig. 6e). This suggests that
uterine tumors can become infected by the E. coli upon which C.
elegans are routinely cultured. Examination of dsRed positive
tumors using light microscopy conﬁrmed the presence of E. coli
within the tumors (data not shown). One possibility is that such
infections are nourished by the rich yolky milieu of the tumor
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(Figure S6c). Such infections are prevented by treatment with the
antibiotic carbenicillin (Fig. 6f), revealing another mechanism by
which antibiotics reduce senescent pathology and, possibly,
extend lifespan.17 Taken together, these ﬁndings illustrate how
distinct etiologies (embryogenetic and vitellogenic quasi-pro-
grams, and bacterial infection) act together in the genesis of a
major senescent pathology.
Is the uterus a latent tumor niche?
Previous histological analysis implied that despite their large size,
tumors remain largely within the uterus.19 To verify this
quantitatively in live animals, we used a COG-1::GFP reporter that
is expressed in the spermathecal-uterine valve, which marks the
distal end of the uterus (and also the vulva). Tumors of 28 worms
were examined on day 8 of adulthood and in all cases where
spermathecal GFP was detectable, this marked the distal end of
the tumor (Figure S7a,b).
That extra-uterine oocytes do not develop into tumors raises
the possibility that the uterus possesses tumor niche properties
that are latent prior to sperm depletion. The latent tumor niche is
a disease etiology paradigm where an unintended juxtaposition of
two tissues leads to induction of the development of pathology.36
This disease mechanism is thought to contribute to early stages of
cancer, prior to mutation, and perhaps to senescent pathology,36
and is another form of quasi-program etiology. For example, if C.
elegans mitotic germ cells are mislocated near the somatic
gonadal sheath, the latter acts as a tumor niche due to Notch
ligand secretion (including DSL-5), resulting in hyperplastic
proximal tumors.36 In tests of Notch ligand gene knock-down
and mutation, we observed that dsl-5(ok588) slows tumor growth
without delaying the timing of sperm depletion (Figure S7c,d).
However, the site of expression of dsl-5 has proved difﬁcult to
determine36 (Supplemental Results). Moreover, reduction of Notch
receptor function after sperm depletion using glp-1(e2141ts) did
not reduce tumor size (Figure S7e) (for further details, see
Supplemental Results). The possibility that a uterine tumor niche
promotes oocyte hypertrophy warrants further investigation.
DISCUSSION
A central claim of the Williams Blagosklonny model (Fig. 1a) is that
developmental quasi-programs promoted by late-life action of
wild-type genes are a major cause of late-life pathology (i.e., of
aging). Previous studies suggest a contributory role for quasi-
programs to senescent pathologies in C. elegans. For example run-
on of physiological apoptosis contributes to atrophy of the
hermaphrodite gonad,37 and run-on of yolk production leads to
yolk steatosis and, through gut-to-yolk biomass conversion, to
intestinal atrophy.6,35 Here, we show how C. elegans senescent
uterine tumors exemplify generation of senescent pathology by
quasi-programs. Importantly, the main etiology deﬁned here, a
parthenogenetic quasi-program, is similar to that of human
ovarian teratomas, demonstrating the conservation of quasi-
programmed etiologies between C. elegans and humans. Thus,
etiologies of native diseases of aging in C. elegans are relevant to
mammalian disease.
Uterine tumors illustrate how antagonistic pleiotropy can be
enacted through quasi-programs
Mutation of the daf-2 insulin/IGF-1 receptor suppresses uterine
tumor development.19 Here daf-2 exhibits antagonistic pleiotropy
(AP), promoting development ﬁrst of germline38 and then of
tumors. Williams originally envisaged AP acting on numerous
genes with discrete phenotypic effects (Figure S8a). From this
perspective, the initial discovery of genes like daf-2 that appear to
affect the entire aging process was unexpected. This paradox was
partially resolved with the realization that daf-2 affects expression
of numerous other genes, including many involved in somatic
maintenance, consistent with the disposable soma theory.39
However, a better ﬁt with uterine tumor pathobiology is
Blagosklonny’s concept of quasi-program: a complex, develop-
mental program that runs on, resulting in the development of
pathology13 (Figure S8b). Here, plausibly, pathology results not
passively from damage accumulation or failure of homeostasis,
but rather actively from gene action (hyper-function; Fig. 1b).
However, it remains possible that stochastic damage and
disposable soma-type AP also contribute to uterine tumor
etiology.19 For example, it was recently shown that absence of
sperm increases protein aggregation in unfertilized oocytes,40
which might contribute to tumor pathophysiology.
Cell cycle run-on causes uterine tumor development
Uterine tumor development appears to originate with run-on of
endomitosis. This leads to polyploidy, nuclear hypertrophy and
cellular hypertrophy. Increased ploidy promotes growth in many
contexts, e.g., in the C. elegans hypodermis,41 and we postulate
that by similar mechanisms increased oocyte ploidy drives cellular
hypertrophy.
In mammals, cancer is considered to be primarily the
consequence of somatic mutations affecting the control of cell
proliferation. However, the age-increase in cancer rate is to some
degree the result of the effect on aging on the cellular
microenvironment.15 Moreover, some forms of cancer can
originate with run-on rather than mutation, for example benign
prostatic hyperplasia (BPH) in humans, which typically precedes
prostate cancer, is the result of long-term testosterone exposure
rather than mutation.42 Thus, the initial cause of BPH, like C.
elegans uterine tumors, appears to be quasi-programs rather than
damage.
Similarities between uterine tumors and mammalian teratomas
C. elegans uterine tumors are pathophysiologically similar to
mammalian ovarian teratomas in several respects. First, both result
from a failure of meiosis II leading to formation of abnormal cells
that are diploid derivatives of immature oocytes. Secondly, in both
cases these cells make a botched attempt to form an embryo,
through futile expression of embryogenetic developmental
Fig. 6 Additional uterine tumor etiologies: yolk uptake and bacterial infection. a VIT-2::GFP accumulation in uterine tumors (day 10 adult),
with cell membranes marked with mCherry::PH. VIT-2::GFP accumulation in oocytes within tumors (arrows) and in yolky pools (arrowheads). T,
uterine tumor. Scale bar, 25 μm. b Neutral lipid staining shows lipid accumulation within uterine tumors, delineated by dotted lines (day 8
adult, 15 μM FUDR). I intestine, T uterine tumor. Scale bar, 25 μm. c vit-5,-6 RNAi reduces tumor size (mean ± s.e.m.). Summed data from 3 trials;
Sidak multiple comparison test, *p < 0.05. Sample sizes on each day: n= 19–32. d rme-2 RNAi reduces tumor size (mean ± s.e.m.). Summed data
from 2 trials. **p < 0.01, ****p < 0.0001. Sample sizes on each day: n= 14–21 (rme-2 RNAi, day 14, n= 5). c, d RNAi initiated at hatching. e, f
Uterine tumors can develop bacterial infections. e E. coli expressing dsRed within uterine tumors (day 10 adult, necropsy). Arrow, infected
pharynx. Arrowhead, infected tumor. Scale bar, 100 μm. f Bar graph showing frequency of worms with infected tumors, without or with
carbenicillin (Fisher Scientiﬁc, 4800-94-6). Pink, uninfected; red, infected. g Scheme summarizing how programs that act to promote
reproduction in young adults (left) become quasi-programs to promote pathology in older adults, after sperm depletion (right). Arrows
indicate a contributory effect
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programs. In the case of C. elegans this gives rise to amorphous
masses derived from hypertrophic, polyploid oocyte-derived cells.
They show expression of genes associated with later embryonic
development, but no detectable morphological differentiation,
and no cell proliferation, in contrast to mammalian teratomas. A
further similarity is that human ovarian teratomas are usually
benign, and C. elegans uterine tumors do not increase late-life
mortality.21
A difference between C. elegans uterine tumors and mammalian
ovarian teratomas is that the former is a senescent pathology but
not the latter, which instead occur largely during reproductive
years (in humans between ~20–40 years of age).43 Nonetheless,
the fact of the etiological features that they share—in broad
terms, quasi-programs resulting from wild-type gene function—
yields a grim insight into the nature of aging: that senescent
pathology and teratoma are to some extent pathophysiologically
equivalent. That is to say, insofar as senescent pathology is caused
by quasi-programs, aging and teratoma are the same sort of
disease; likewise, cholera and tuberculosis are the same sort of
disease, insofar as both are caused by bacterial infection.
It was previously shown that disruption of P granules (germ
granules) also caused de-repression of somatic gene expression in
the germline, including unc-119.44 An unexplored possibility is that
loss of P granules might trigger such de-repression in older
tumors.
Multiple etiologies of tumorigenesis
Uterine tumors illustrate how different etiologies combine to
cause senescent pathology (summarized in Fig. 6g). Here the
initial etiology is run-on of embryogenetic quasi-programs.
Subsequently, a second pathology, yolk steatosis, contributes to
tumor growth, in a distant parallel to the increased cancer risk
caused by obesity in mammals. Thirdly, tumors can become
infected with bacteria, and here again there are resemblances to
mammalian pathogenesis, as follows.
The relationship between bacteria and cancer progression in
humans is a long-standing topic of investigation. In some
instances, bacteria appear to initiate or drive malignant altera-
tions. For example, colorectal cancer is often associated with an
abundance of Streptococcus gallolyticus and Fusobacterium sp,
which are thought to trigger and drive cancer progression by
causing persistent inﬂammation.45,46 Here, the anaerobic condi-
tions and available nutrients within tumors provide an optimum
environment for the growth of certain bacteria.45 However,
bacterial infection of tumors is not necessarily detrimental to
the host. Post-operative infection in lung cancer can actually
improve patient survival,47 perhaps because bacteria compete for
nutrients, secrete toxic proteins or help to initiate immune
responses against tumor cells. Given the susceptibility of
C. elegans uterine tumors to bacterial invasion as demonstrated
here, they could serve as a model to study tumor–bacteria
interactions.
CONCLUSIONS
The main purpose of studying aging in C. elegans is to understand
senescence, particularly in terms of its initial causes. This is part of
the broader, general goal of biomedical research: to understand
the etiologies of disease in order to be able to prevent and treat
them.48 This study describes the primary mechanistic cause of one
component of C. elegans aging, uterine tumor development. This
exempliﬁes a class of diseases of aging caused by quasi-programs
that appear to play a major role in the C. elegans aging process.
We speculate that in C. elegans, quasi-programs are the
predominant cause of senescence, along with other contributory
causes, such as mechanical senescence and bacterial infection
(this study).49,50 However, in mammalian aging molecular damage,
particularly DNA damage, may play a greater role than in C.
elegans.
MATERIALS AND METHODS
C. elegans culture and strains
Worms were cultured at 20 °C unless otherwise stated. Nematode strains
used in this paper include N2 (wild-type) CGCH,51 CB4108 fog-2(q71) V,
GA1932 unc-119(ed.3) III; ltIs44 [pie-1p-mCherry::PH(PLC1deltal)+unc-119
(+)]; ruIs32 [pie-1::GFP::H2B+unc-119(+)] III and PS3662 syIs63[cog-1::GFP
+unc-119(+)]. For full listing see Supplemental Experimental Procedures.
Selective plane illumination microscopy (SPIM)
SPIM was used to make 3D reconstructions of C. elegans uterine tumors.
Anaesthetized worms were transferred into a plastic capillary tube with
1.5% low melting point agarose, 0.03% levamisole and 0.5 μM FluoSphere
microspheres (beads) (1:1000, F8813 from Life Technologies). FluoSphere
beads allowed registration and 3D construction of 2D images taken from 5
angles. OpenSPIM was performed to take images as previously
described.52
Pathology measurements
Severity of uterine tumors were scored using a ﬁve stage classiﬁcation as
described.21 To measure different levels of nuclear hypertrophy we created
another ﬁve stage classiﬁcation. Score 1 denotes small, spherical early stage
oocyte nuclei. Score 2 denotes larger but still spherical nuclei. Score 3
denotes larger nuclei with irregular morphology. Score 4 denotes highly
hypertrophic nuclei with grossly abnormal phenotype (e.g., with major
protrusions), such that some individual nuclei are barely distinguished.
Score 5 denotes large chromatin masses where most individual nuclei
can no longer be distinguished. Trials were initiated with L4 stage larvae
(day 0).
Statistical analysis
Statistical tests with appropriate assumptions on data distribution were
used. Correlation analysis was performed using linear regression analysis.
Non-parametric Wilcoxon–Mann Whitney test was performed to compare
uterine status and nuclear morphology. Fluorescence intensity was
measured using Volocity and Fiji software. Multiple comparison t-test
was used to compare ﬂuorescence intensity and tumor size.
For additional detail on methodology, see Supplemental Experimental
Procedures.
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